A process for recovering one or more blastocysts from a uterus of a human is disclose which comprises placing a device transvaginally into a cervical canal of the patient; delivering fluid through the device to the uterus and applying a vacuum to the uterus to aspirate fluid and entrained one or more blastocysts from the uterus; and causing a disruption of to the uterus and/or to one or more embryos remaining in the uterus following removal of one or more blastocysts from the uterus to reduce the chance that any such retained embryos remaining in the uterus will form a viable pregnancy, wherein the causing a disruption comprises one or more of the following: inducing a mechanical disruption of the uterus, delivering a hormonal agent to the uterus, delivering a chemical agent to the uterus, inducing a thermal disruption of the uterus, or using ultrasound or radiofrequency energy to induce said disruption. Kits and uterine lavage systems are further provided for performing the processes described in the invention.

A sterile liquid transfer assembly for use with a catheter assembly. The sterile liquid transfer assembly includes a protective element and a carrier element. The protective element includes a pliable, hollow protective valve member having a pivot cutaway portion. A tubular member of the protective element depends from a surface of the hollow protective valve member. The protective valve member is configured to define a stop for limiting the insertion of the tubular member in a canal of a patient.

Devices, systems and methods for localized delivery of a chemotherapy, hormonal therapy or targeted drug/biologic therapy to a target tissue area of an internal body organ of a patient. A catheter forms a sealed treatment chamber in a natural lumen extending through the target tissue area. Air is purged from the chamber, which is then filled with a liquid drug solution for an adequate treatment session time, solution volume and drug concentration to saturate the target tissue area, thereby providing the treatment. The liquid drug solution may be circulated or recirculated through the chamber or maintained stationary therewithin. The drug may saturate the target tissue area and pass therethrough into the lymphatic system or interstitial space, which may serve as a reservoir of the drug for continued therapeutic treatment after withdrawal of the catheter. The chamber is evacuated at the end of the treatment session.

Everting balloon systems and methods for using the same with an alignment element for stability and anti-rotation of the everting balloon are disclosed herein. The systems can be configured to access and deliver instruments, media, or other catheters into bodily lumens and cavities. The alignment element can eliminate the potential for the everting membrane to become twisted or rotated which could impact access or the ability of the system to deliver materials. A compliance member can facilitate internal pressurization of the everting catheter system. An everting catheter system can be configured for use with transvaginal ultrasound and a lower profile speculum is described.

A postpartum balloon system includes a flexible elongate catheter, an inflatable balloon, and a suction member attached to the distal end of the catheter. The system can be delivered into the uterus, where suction is applied to the suction member to anchor the balloon to the internal wall of the uterus. The catheter may include drainage ports both proximal and distal from the balloon. The system may include a stiffening stylet inserted into the drainage lumen of the catheter for aiding in delivery of the balloon. The stiffening stylet can be removed after placement of the balloon. The stiffening stylet can include side passageways that match the drainage ports and a lumen that allows for drainage through the stylet, as well as for administering drugs or other compounds through the drainage ports while the balloon is in place.

An external uterine compression wrap has a sheet like structure with an unfolded configuration and a folded configuration. The sheet is configured to be wrapped around the uterus and secured in the folded configuration to provide external compression to the uterus to treat postpartum hemorrhage. The wrap may include securement members attached to the sheet at one end that extend through corresponding passageways at the opposite end, such that the sheet when folded may be retained in the folded configuration after the securement members have been secured. The wrap may include a securement member in the form of a suture that extends along at least a portion of the perimeter of the sheet through spaced apart holes, and the suture may be pulled to cinch the sheet around the uterus in a folded configuration.

An occlusion device includes a body having a plurality of layers and defining a first diameter. Each layer of the plurality of layers is releasably coupled to a respective inwardly-adjacent layer. An outermost layer of the plurality of layers is removable from the respective inwardly-adjacent layer. Removal of the outermost layer reduces an outer diameter of the body from the first diameter to a second diameter that is less than the first diameter.

Device for vaginal access to the uterus of a livestock animal for transfer of material or collecting samples, includes a body integrally connected to gripping element, a first passage extending through the device and opening out at two ends in order to establish an access route between the inside and the outside of the animal, the body being straight and rigid in order to permit introduction into the vagina, and a cup being provided at its distal end, a projection extending from the bottom of the cup and having a through-hole in communication with the first passage, the cup having an orifice in communication with a second passage extending through the body and connected to suction element, to place the cup flat against the fornix of the neck of the uterus, with viewing element likewise being provided in order to permit viewing at the front of the cup.

An embryo transfer catheter (10) is described comprising an outer catheter body (12) having first and second lumens (14, 16). The second lumen (16) is adapted to receive an internal catheter (not shown) with a single lumen which, in use, will allow passage of an embryo or embryo-containing cannula (not shown) into the uterus (18) of the recipient. An inflatable balloon (20) is provided at a distal end of the first lumen (14). The inflatable balloon (20) is designed to be as small as possible in its inflated condition while still being retained in the uterus (18). The shape of the balloon (20) is adapted in its inflated state to conform to just the lowest part of the uterus (18). The aim in designing the balloon (20) as small as possible is to leave as much endometrium accessible to the embryo for implantation as possible, and to occupy as little volume as possible within the uterine cavity and to exert as little pressure as possible to avoid causing contractions, while still being retained in the uterus (18).

A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.